echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Pharmaceutical Marketing > Is China's epidemic prevention and control being liberalized too quickly? How to prevent and control new strains? Official response

    Is China's epidemic prevention and control being liberalized too quickly? How to prevent and control new strains? Official response

    • Last Update: 2023-02-03
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    In response to whether China's epidemic prevention and control is too fast, Liang Wannian, head of the expert group of the new crown epidemic response leading group of the National Health Commission of China, said in an interview with the media in Beijing on the 29th that the adjustment of China's epidemic prevention and control policy is based on the understanding of pathogens and diseases, the level of population immunity and the resistance of the health system, and the judgment of social public health interventions, and the current adjustment is appropriate, scientific, and in accordance with the law, in line with the reality of China's
    prevention and control.
     
    Liang Wannian stressed that since the beginning of epidemic prevention and control in 2020, China has been closely judging three factors, one is the understanding of pathogens and diseases, such as its toxicity and harmfulness, the second is the level of population immunity and the resistance of the health system, especially the prevention and control ability and medical treatment ability, and the third is social public health interventions
    .
    In the face of a major epidemic, China has always considered that these three aspects should be balanced in an effort to achieve a balance
    .
     
    Liang Wannian said that around this basic theoretical framework and thinking, with the deepening of people's understanding of diseases and pathogens, the gradual establishment of population immunity levels, and the enhancement of resistance resilience, China has continuously improved diagnosis and treatment plans and prevention and control plans
    according to the situation.
    From the nine versions of the prevention and control plan, twenty optimization measures, and the "new ten" since 2020 to the adjustment to "Class B and B pipe", all reflect the balanced results
    of these three factors in China.
     
    Liang Wannian said that this adjustment is not completely laissez-faire, but more scientific and accurate to put resources on the most important prevention and control tasks and treatment tasks
    .
    "I think history will prove the speed of this adjustment, and we believe that the current adjustment is appropriate, scientific, and in accordance with the law, in line with China's
    prevention and control reality.
    "
     
    In response to foreign remarks that China does not provide genome sequence data of virus strains, Wu Zunyou, chief expert in epidemiology at the Chinese Center for Disease Control and Prevention, responded that one of the main tasks of the Institute of Virus Disease Prevention and Control of the Chinese Center for Disease Control and Prevention is to analyze, sequence and report
    virus strains across the country.
     
    He pointed out that when the epidemic first occurred in Wuhan, the Chinese Center for Disease Control and Prevention uploaded the gene sequence to the World Health Organization's influenza sharing platform for the first time, so that countries can develop diagnostic reagents and vaccines
    based on this gene sequence.
    Subsequently, the epidemic situation in China was mainly imported from abroad to China, causing local transmission, and each time a new strain was caught by the Chinese Center for Disease Control and Prevention, it was uploaded
    in time.
     
    "Including this wave of the epidemic, there are nine Omicron strains circulating in China, and these results have been shared with the World Health Organization, so China does not have any secrecy, and all the work is shared
    with the world.
    " Wu Zunyou said
    .
     
    Talking about how to prevent and control new strains in the future, Liang Wannian said that China pays great attention to the monitoring of pathogen mutations and actively participates in global pathogen surveillance
    .
    Once a new variant is discovered, or the mutation leads to changes in the pathogenicity, transmissibility and virulence of the virus, China will promptly notify the World Health Organization and make corresponding optimizations, improvements and adjustments
    in prevention and control plans and medical treatment.
    (End)
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.